X-139561565-C-T
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PS4PVS1_StrongPP4_ModeratePM2_Supporting
This summary comes from the ClinGen Evidence Repository: The F9 c.880C>T (Arg294Ter) variant occurs in exon 8/8 of the F9 gene, and NMD is not predicted. PVS1_Strong is applied based on truncation of the Peptidase S1 domain. This variant is completely absent from gnomAD v2.1.1 and v3.1.1, meeting PM2_Supporting criteria. Over 90 patients have been reported in the literature and the EAHAD database with hemophilia B in the moderate-severe range and history of inhibitors to factor replacement products are reported, meeting PP4_Moderate and PS4_Very strong (selected PMIDs: 29296726, 8217825, 8314564). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_VeryStrong, PVS1_Strong, PP4_Moderate, PM2_Supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA255344/MONDO:0010604/080
Frequency
Consequence
NM_000133.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- hemophilia BInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- mild hemophilia BInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- moderately severe hemophilia BInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- severe hemophilia BInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- symptomatic form of hemophilia B in female carriersInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- thrombophilia, X-linked, due to factor 9 defectInheritance: XL Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000133.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| F9 | NM_000133.4 | MANE Select | c.880C>T | p.Arg294* | stop_gained | Exon 8 of 8 | NP_000124.1 | ||
| F9 | NM_001313913.2 | c.766C>T | p.Arg256* | stop_gained | Exon 7 of 7 | NP_001300842.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| F9 | ENST00000218099.7 | TSL:1 MANE Select | c.880C>T | p.Arg294* | stop_gained | Exon 8 of 8 | ENSP00000218099.2 | ||
| F9 | ENST00000394090.2 | TSL:1 | c.766C>T | p.Arg256* | stop_gained | Exon 7 of 7 | ENSP00000377650.2 | ||
| F9 | ENST00000643157.1 | n.1547C>T | non_coding_transcript_exon | Exon 6 of 7 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Hereditary factor IX deficiency disease Pathogenic:4
The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through protein truncation. Multiple pathogenic variants are reported in the predicted truncated region. The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID: 22544209, 26612714). The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000010587 /PMID: 2270538). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.
The F9 c.880C>T (Arg294Ter) variant occurs in exon 8/8 of the F9 gene, and NMD is not predicted. PVS1_Strong is applied based on truncation of the Peptidase S1 domain. This variant is completely absent from gnomAD v2.1.1 and v3.1.1, meeting PM2_Supporting criteria. Over 90 patients have been reported in the literature and the EAHAD database with hemophilia B in the moderate-severe range and history of inhibitors to factor replacement products are reported, meeting PP4_Moderate and PS4_Very strong (selected PMIDs: 29296726, 8217825, 8314564). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_VeryStrong, PVS1_Strong, PP4_Moderate, PM2_Supporting.
not provided Pathogenic:2
Nonsense variant predicted to result in protein truncation, as the last 168 amino acids are lost, and other loss-of-function variants have been reported downstream in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31589614, 28270892, 27109384, 38196513, 33760382, 2270538, 31064749, 35842956, 26612714, 22618954, 8314564, 8217825, 34590426, 36347023, 22544209, 10595634, 24375831, 33999344)
PP5, PM2_moderate, PS4_moderate, PVS1
not specified Pathogenic:1
The F9 c.880C>T; p.Arg294Ter variant (rs137852248), also known as p.Arg248Ter in traditional nomenclature, is reported in the literature in multiple individuals affected with moderate to severe hemophilia B (Factor IX database and references therein). This variant is reported as pathogenic in ClinVar (Variation ID: 10587), and is absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. This variant results in a premature termination codon in the last exon of the F9 gene. While this may not lead to nonsense-mediated decay, it is expected to create a truncated protein, and other downstream nonsense variants have been reported in individuals with hemophilia and are considered pathogenic (Factor IX database and references therein). Based on available information, the p.Arg294Ter variant is considered to be pathogenic. References: Factor IX database: http://www.factorix.org/
Hereditary factor IX deficiency disease;C2749016:Thrombophilia, X-linked, due to factor 9 defect Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg294*) in the F9 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 168 amino acid(s) of the F9 protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with haemophilia (PMID: 2270538, 8217825, 8314564, 10595634, 22544209, 23093250, 24375831, 26612714). This variant is also known as p.Arg248*. ClinVar contains an entry for this variant (Variation ID: 10587). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at